Ainos (Nasdaq: AIMDW) files $874,496 ATM stock supplement

Rhea-AI Filing Summary

Ainos, Inc. filed an 8-K to report an update to its at-the-market stock offering program with H.C. Wainwright & Co., LLC as placement agent. The company previously established an agreement on May 31, 2024 to sell common stock with an aggregate offering price of up to $1,353,197, which was increased by a July 11, 2024 prospectus supplement to $1,840,350. Ainos has already sold common shares with an aggregate sales price of approximately $1,840,337 under this program. On September 5, 2025, Ainos filed a new prospectus supplement for an additional $874,496 of common stock under the same at-the-market agreement.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001014763 0001014763 2025-09-05 2025-09-05 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2025-09-05 2025-09-05 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2025-09-05 2025-09-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 5, 2025

AINOS, INC.

(Exact name of registrant as specified in its charter)

Texas		001-41461		75-1974352
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

8880 Rio San Diego Drive, Ste. 800, San Diego, CA 92108

(858) 869-2986

(Address and telephone number, including area code, of registrant’s principal executive offices)

(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		AIMD		The Nasdaq Stock Market LLC
Warrants to purchase Common Stock		AIMDW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

As previously reported, on May 31, 2024, Ainos, Inc. (the “Company”) entered into an At The Market Offering Agreement (the “Agreement”) with H.C. Wainwright & Co., LLC as placement agent (the “Placement Agent”) to offer and sell shares of its common stock, par value $0.01 per share (“Common Stock”), having an aggregate offering price of up to $1,353,197 from time to time through the Placement Agent. On July 11, 2024, the Company filed a prospectus supplement under the Agreement to increase the aggregate offering price of Common Stock to be offered and sold under the Agreement to $1,840,350. Prior to the date hereof, the Company sold shares of Common Stock having an aggregate sales price of approximately $1,840,337 under the Agreement. On September 5, 2025, the Company filed a prospectus supplement under the Agreement for an aggregate of $874,496 of additional shares of Common Stock.

A copy of the legal opinion of Lucosky Brookman LLP, relating to the validity of the shares in connection with the Agreement is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statement and Exhibits

(d) Exhibits.

Exhibit No.		Description
5.1		Opinion of Lucosky Brookman LLP.
23.1		Consent of Lucosky Brookman LLP (included in Exhibit 5.1)
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Ainos, Inc.
Date: September 8, 2025	By:	/s/ Chun-Hsien Tsai
	Name:	Chun-Hsien Tsai
	Title:	Chief Executive Officer

FAQ

What did Ainos (AIMDW) disclose in this 8-K filing?

Ainos reported that it filed a new prospectus supplement under its existing at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell additional shares of common stock with an aggregate offering price of $874,496.

How large is Ainoss current at-the-market offering program?

The at-the-market agreement was originally for up to $1,353,197 of common stock and was later increased by a July 11, 2024 prospectus supplement to $1,840,350, with a new September 5, 2025 supplement covering an additional $874,496 of common stock.

How much stock has Ainos already sold under the at-the-market agreement?

Before the new September 5, 2025 prospectus supplement, Ainos had sold shares of common stock with an aggregate sales price of approximately $1,840,337 under the at-the-market agreement.

Who is the placement agent for Ainoss at-the-market stock sales?

H.C. Wainwright & Co., LLC serves as the placement agent for Ainoss at-the-market offering of common stock under the agreement.

What legal opinion is included with this Ainos 8-K filing?

The filing includes as Exhibit 5.1 a legal opinion from Lucosky Brookman LLP regarding the validity of the shares issued in connection with the at-the-market agreement, along with a related consent in Exhibit 23.1.

Which securities of Ainos are listed on Nasdaq?

Ainos has its common stock, par value $0.01 per share, listed under the symbol AIMD, and its warrants to purchase common stock listed under the symbol AIMDW on The Nasdaq Stock Market LLC.